Occam Places Steve Staben as CSO at Lycia Therapeutics
Lycia Therapeutics, Inc., a leader in extracellular protein degradation has appointed Steve Staben, Ph.D., as Chief Scientific Officer. Prior to joining Lycia, Dr. Staben spent over 14 years at Genentech leading drug discovery programs in oncology and immunology as well as new modality platforms.
Steve has co-authored over 70 peer-reviewed articles and patent applications and holds his Ph.D. in organic chemistry from the University of California, Berkeley.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.